← All organizations

JADO Technologies GmbH

For profitContributed to NME

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Apr 1, 2007

Defunct as of Apr 25, 2013

Timeline

2000s

Jun 1, 2001
JADO Technologies GmbH— Founded

2010s

Apr 25, 2013
JADO Technologies GmbH— Defunct

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

miltefosine

Indications

Studied for

Recent trials (1)

NCT00457288Lead sponsorPhase 2Apr 1, 2007

Details

Founded: Dresden, DE Jun 1, 2001
Last known activity: Apr 1, 2007